Add office photos
Employer?
Claim Account for FREE
AstraZeneca
4.1
based on 819 Reviews
Video summary
Company Overview
Company Locations
Working at AstraZeneca
Company Summary
AstraZeneca is a global, science-led biopharmaceutical business. Their innovative medicines are used by millions of patients worldwide.
Overall Rating
4.1/5
based on 819 reviews
5% above
industry average
Highly rated for
Work-life balance, Company culture, Job security
Work Policy
Hybrid
82% employees reported
Monday to Friday
65% employees reported
Flexible timing
75% employees reported
No travel
47% employees reported
View detailed work policy
Top Employees Benefits
Office cab/shuttle
109 employees reported
Free meal
107 employees reported
Health insurance
107 employees reported
Cafeteria
84 employees reported
View all benefits
About AstraZeneca
Founded in1999 (26 yrs old)
India Employee Count501-1k
Global Employee Count50k-1 Lakh
HeadquartersCambridge, Cambridgeshire, United Kingdom (UK)
Office Locations
--
Websiteastrazeneca.com
Primary Industry
Other Industries
Are you managing AstraZeneca's employer brand? To edit company information,
claim this page for free
View in video summary
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Managing your company's employer brand?
Claim this Company Page for FREE
AstraZeneca Ratings
based on 819 reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
402
4
250
3
87
2
30
1
50
Category Ratings
4.1
Work-life balance
3.9
Company culture
3.9
Job security
3.9
Salary
3.8
Skill development
3.8
Work satisfaction
3.4
Promotions
AstraZeneca is rated 4.1 out of 5 stars on AmbitionBox, based on 819 company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at AstraZeneca
based on 759 reviews
4.0
Rated by 176 Women
Rated 3.9 for Work-life balance and 3.9 for Job security
4.1
Rated by 583 Men
Rated 4.2 for Work-life balance and 4.0 for Company culture
Work Policy at AstraZeneca
based on 72 reviews in last 6 months
Hybrid
82%
Work from office
18%
AstraZeneca Reviews
Top mentions in AstraZeneca Reviews
+ 5 more
Compare AstraZeneca with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.1/5 based on 819 reviews | 4.1/5 based on 1.6k reviews | 4.0/5 based on 1.8k reviews | 4.1/5 based on 1.8k reviews |
Highly Rated for | Work-life balance Salary Job security | Work-life balance Company culture Salary | Work-life balance Company culture Skill development | Company culture Skill development Work-life balance |
Critically Rated for | No critically rated category | Promotions | Promotions | No critically rated category |
Primary Work Policy | Hybrid 82% employees reported | Hybrid 86% employees reported | Work from office 53% employees reported | Hybrid 70% employees reported |
Rating by Women Employees | 4.0 Good rated by 176 women | 4.1 Good rated by 373 women | 4.0 Good rated by 222 women | 4.2 Good rated by 274 women |
Rating by Men Employees | 4.1 Good rated by 583 men | 4.1 Good rated by 1.1k men | 4.0 Good rated by 1.4k men | 4.1 Good rated by 1.4k men |
Job security | 3.9 Good | 3.8 Good | 3.4 Average | 3.7 Good |
View more
AstraZeneca Salaries
AstraZeneca salaries have received with an average score of 3.9 out of 5 by 819 employees.
Senior Consultant
(341 salaries)
Unlock
₹10 L/yr - ₹36 L/yr
Territory Business Manager
(217 salaries)
Unlock
₹2.8 L/yr - ₹11.3 L/yr
Associate Engineer
(191 salaries)
Unlock
₹3.7 L/yr - ₹9 L/yr
Senior Engineer
(153 salaries)
Unlock
₹8 L/yr - ₹25 L/yr
Analyst
(130 salaries)
Unlock
₹5.9 L/yr - ₹22.3 L/yr
Key Account Manager
(119 salaries)
Unlock
₹5.5 L/yr - ₹14.8 L/yr
Software Engineer
(92 salaries)
Unlock
₹4.6 L/yr - ₹18 L/yr
Clinical Research Associate
(75 salaries)
Unlock
₹4 L/yr - ₹9.3 L/yr
Area Business Manager
(67 salaries)
Unlock
₹11.7 L/yr - ₹21 L/yr
Junior Associate
(62 salaries)
Unlock
₹4.4 L/yr - ₹10 L/yr
AstraZeneca Interview Questions
Interview questions by designation
Top AstraZeneca interview questions and answers
Get interview-ready with top interview questions
AstraZeneca Jobs
Popular Designations AstraZeneca Hires for
Popular Skills AstraZeneca Hires for
Current Openings
AstraZeneca News
View all
Stock Market Today: All You Need To Know Going Into Trade On Feb. 12
- The Indian equity benchmark indices, NSE Nifty 50 and BSE Sensex, closed lower with the Nifty down 1.32% and Sensex 1.31% lower.
- Asian stocks had a mixed day with Japan's Nikkei 225 up, while South Korea's Kospi and Australia's S&P/ASX 200 remained unchanged. Hang Seng futures declined.
- US stocks fluctuated, bond yields rose after Federal Reserve Chair Jerome Powell reiterated no rush to cut rates. S&P 500 and Dow Jones had little changes.
- Foreign portfolio investors were net sellers of Indian equities, while domestic institutional investors were net buyers.
- The rupee closed stronger against the US dollar on Tuesday.
- Earnings highlights post-market hours included results from companies like Birlasoft, Vodafone Idea, AstraZeneca Pharma India, Berger Paints, IRCTC, Time Technoplast, Technocraft Industries, NBCC (India), and more.
- Stocks to watch included TVS Motor Co., H.G. Infra Engineering, Hatsun Agro Product, Jupiter Wagons, BEML, Bharat Heavy Electricals, and Happy Forgings.
- IPO offerings mentioned were Ajax Engineering and Hexaware Technologies with details on subscription rates.
- Insider trading updates related to Paisalo Digital and GPT Infraprojects were reported, along with bulk deals in Sterling and Wilson Renewable Energy.
- Trading tweaks like price band changes, ex-dividend listings, and stocks moving in and out of short-term ASM framework were observed.
- F&O cues showed Nifty Feb futures down, options data, and securities in the ban period.
Bloomberg Quint | 12 Feb, 2025
AstraZeneca Pharma India Gets Warning Letter From NSE
- AstraZeneca Pharma India received a warning letter from the National Stock Exchange (NSE) for non-compliance with a regulatory norm.
- The company violated the provision that mandates the attendance of at least two independent directors in an audit committee meeting.
- NSE advised AstraZeneca Pharma India to exercise caution, take corrective steps, and avoid recurrence of such lapses.
- The stock of AstraZeneca Pharma India closed 0.81% lower at Rs 7,550 apiece on the NSE.
Bloomberg Quint | 10 Feb, 2025
Union Budget 2025: Cancer medicines and patient assistance programmes come in for reprieve
- Medicines from multinational companies, including Pembrolizumab (MSD Pharma), Lorlatinib (Pfizer), Ribociclib (Novartis), Selumetinib (Astra Zeneca), Teclistamab (Johnson & Johnson), Cetuximab (Merck Specialities), Brentuximab Vedotin (Takeda); Mepolizumab (GSK Pharma), Risdiplam Powder (Roche), Luspatercept (Bristol Myers Squibb) are among the 37 listed to get Basic Customs Duty exemptions, provided they are given free.
- Additionally, the budget proposes to add 13 new patient assistance programs for supplying medicines free of cost to patients.
- 36 lifesaving drugs and medicines will be added to the list of medicines fully exempted from Basic Customs Duty (BCD), and 6 lifesaving medicines will be eligible for concessional customs duty of 5 percent.
- The budget also plans to establish 200 daycare cancer centers in all district hospitals in the next three years.
HinduBusinessLine | 1 Feb, 2025
Jobs Reports Due for Next Week
- The report contains jobs numbers from the US and Canada along with their featured earnings for the upcoming week.
- Monday will see the announcement of economic data regarding the S&P's final US manufacturing PMI, Construction spending, ISM manufacturing and Auto Sales for January.
- On Tuesday, reports will be published announcing job openings data and factory orders for December in the US, as well as the Canadian international merchandise trade for December.
- Wednesday will bring information about ADP employment, US trade deficit, the S&P final US services PMI and ISM services.
- Thursday will see the release of the US initial jobless claims, US productivity for Q4 along with featured earnings for companies including Amazon.com Inc., Eli Lilly And Co, and AstraZeneca PLC.
- Friday will announce the US employment report for January, wholesale inventories and Consumer sentiment, along with earnings from Southern Copper Corp, Fortive Corporation and Kimco Realty Corporation.
- This week's earnings reports include Palantir Technologies, NXP Semiconductors NV, IDEXX Laboratories, Char Technologies, LithiumBank Resources Corp, and TMX Group Limited for Monday.
- On Tuesday, earnings for Alphabet Inc, Toyota Motor Corporation, and Merck & Co Inc will be announced.
- Wednesday's earnings reports include those of NovoNordisk, Alibaba Group Holding Ltd and Walt Disney Co.
- Thursday's featured earnings reports include BCE Inc., Bombardier Inc., Canada Goose Holdings Inc, Colliers International Group Inc., Constellation Software Inc and Lightspeed Commerce Inc.
- Friday's earnings reports include ARC Resources, CAE Inc. Unlimited and Canopy Growth Corporation.
Baystreet | 1 Feb, 2025
AstraZeneca India MD Says Pact With Mankind Pharma Helped Boost Asthma Drug's Reach
- AstraZeneca Pharma India has stated that its partnership with Mankind Pharma has helped boost the reach of its asthma drug, Symbicort.
- The exclusive agreement between AstraZeneca and Mankind Pharma allows for the distribution of Symbicort in India.
- AstraZeneca retains the intellectual property rights and marketing authorization for the drug, while Mankind Pharma handles distribution.
- The partnership aims to make Symbicort more accessible to a larger population in India and has contributed to AstraZeneca Pharma India's revenue growth.
Bloomberg Quint | 3 Dec, 2024
AstraZeneca Pharma India Gets Approval To Import And Distribute Lynparza Cancer Drug
- AstraZeneca Pharma India has received approval from the Indian drug regulator for the import, sale, and distribution of cancer treatment drug Lynparza.
- The approval is for the import and distribution of Olaparib film-coated Tablets 100 mg and 150 mg (Lynparza).
- Lynparza is indicated for the maintenance treatment of adult patients with advanced or recurrent endometrial cancer.
- The permission paves the way for the launch of Lynparza in India, subject to related statutory approvals.
Bloomberg Quint | 26 Nov, 2024
Lunit, AstraZeneca Partner to Develop AI-Powered Pathology Tools for Faster Lung Cancer Diagnostics
- Lunit and AstraZeneca have partnered to develop AI-powered pathology tools for faster lung cancer diagnostics.
- The collaboration aims to improve cancer treatment by analyzing tissue samples and predicting genetic mutations using AI.
- The initial focus is on developing Lunit SCOPE Genotype Predictor, an AI tool for predicting non-small cell lung cancer (NSCLC) driver mutations.
- The AI-powered tool will streamline diagnostic workflows, prioritize molecular testing, and personalize cancer treatment based on individual genetic profiles.
Hitconsultant | 19 Nov, 2024
Why Big Pharmaceuticals and Biotech Shares Fell
- Stock markets are not happy with Trump’s pick of Robert F. Kennedy Jr. to lead HHS.
- SPDR Biotech ETF (XBI) lost 11.85% of its value in the last week.
- This move creates uncertainties for the vaccine market, causing delays in vaccine approvals and potentially slowing down approvals for new drugs as well.
- Investors are advised to wait until early 2025 before re-initiating a position in biotech and drug manufacturers.
Baystreet | 18 Nov, 2024
Pharma shares hit as Trump picks RFK Jr to lead health department
- Investors in pharmaceutical companies are selling off stock after Donald Trump nominated the anti-vaccine activist Robert F Kennedy Jr to lead the US Department of Health and Human Services.
- RFK Jr has embraced numerous health-related conspiracy theories, including linking vaccines to autism and claiming that some antidepressants are linked to school shootings.
- Shares in major pharmaceutical companies, such as Moderna, AstraZeneca, and GSK, fell following the announcement.
- RFK Jr's nomination has drawn widespread criticism, with concerns raised about the potential impact on public health infrastructure and vaccine distribution systems.
Guardian | 15 Nov, 2024
Stock Market Today: All You Need To Know Going Into Trade On Nov. 14
- The US stock markets opened on a flat note on Wednesday, as the rally triggered by Donald Trump's presidential poll victory looks to halt.
- The NSE Nifty 50 ended at over a four-month low for the second session in a row.
- Overseas investors remained net sellers of Indian equities for the 33rd consecutive session on Wednesday.
- Avanti Feeds, Bharat Forge, and Cipla are in focus today as their earnings are declared.
- Thermax, Eicher Motors, Astrazeneca Pharma, Vodafone Idea, Forty stocks are scheduled to announce quarterly results after-market hours on Friday.
- The Indian rupee closed flat at 84.38 against the US dollar on Wednesday, holding near its all-time low of 84.4162.
- Wipro, Indian Overseas Bank, Tata Communications, and Tata Power are some stocks to keep an eye on.
- Niva Bupa Health Insurance Company's shares debut on Thursday.
- The public issue of Zinka Logistics Solution was subscribed to 0.24 times on day 1.
- PNB Housing Finance and Uflex were pledged by their promoters.
Bloomberg Quint | 14 Nov, 2024
Powered by
AstraZeneca Offices
Compare AstraZeneca with
Sanofi
4.3
Merck
4.3
Johnson & Johnson
4.0
Abbott
4.1
Bayer
4.1
Eli Lilly and Company
3.9
Roche Diagnostics
3.8
Granules India
3.8
Unichem Laboratories
3.8
Piramal Pharma
4.0
Strides Pharma
4.0
Jubilant Pharmova
3.9
Natco Pharma
4.0
Flamingo Pharmaceuticals
3.2
Novartis Healthcare
4.1
Concord Biotech
3.7
Bliss Gvs Pharma
4.2
Marksans Pharma
3.2
Gufic Biosciences
3.4
Caplin Point Laboratories
3.8
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to AstraZeneca
Pfizer
Manufacturing, Pharma
4.0
• 1.8k reviews
GlaxoSmithKline Pharmaceuticals
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Pharma
4.1
• 1.8k reviews
Merck
Pharma
4.3
• 305 reviews
Johnson & Johnson
Manufacturing
4.0
• 1.4k reviews
Eli Lilly and Company
Pharma
3.9
• 419 reviews
Roche Diagnostics
Biotech & Life sciences, Internet, Pharma
3.8
• 228 reviews
Granules India
Manufacturing, Pharma
3.8
• 1.2k reviews
Unichem Laboratories
Pharma
3.8
• 1.1k reviews
AstraZeneca FAQs
When was AstraZeneca founded?
AstraZeneca was founded in 1999. The company has been operating for 26 years primarily in the Pharma sector.
Where is the AstraZeneca headquarters located?
AstraZeneca is headquartered in Cambridge, Cambridgeshire.
How many employees does AstraZeneca have in India?
AstraZeneca currently has more than 900+ employees in India. Engineering - Software & QA department appears to have the highest employee count in AstraZeneca based on the number of reviews submitted on AmbitionBox.
Does AstraZeneca have good work-life balance?
AstraZeneca has a work-life balance rating of 4.1 out of 5 based on 800+ employee reviews on AmbitionBox. 80% employees rated AstraZeneca 4 or above on work-life balance. This rating reflects the company's efforts to help employees maintain a healthy balance between their personal and professional lives. We encourage you to read AstraZeneca work-life balance reviews for more details
Is AstraZeneca good for career growth?
Career growth at AstraZeneca is rated as moderate, with a promotions and appraisal rating of 3.4. 20% employees rated AstraZeneca 3 or below, while 80% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading AstraZeneca promotions/appraisals reviews for more detailed insights.
What are the pros of working in AstraZeneca?
Working at AstraZeneca offers several advantages that make it an appealing place for employees. The company is highly rated for work life balance, company culture and job security, based on 800+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
